12 Einträge gefunden

1. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

   1. Klyuchnikov, Evgeny
   2. Sputtek, Andreas
   3. Slesarchuk, Olga
   4. Lioznov, Michael
   5. Stübig, Thomas
   6. Bacher, Ulrike
   7. Amtsfeld, Gitta

   2011 - Forschungsinformationssystem des UKE
2. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

   1. Bacher, Ulrike
   2. Haferlach, Torsten
   3. Fehse, Boris
   4. Schnittger, Susanne
   5. Kröger, Nicolaus

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
3. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

   1. Alchalby, Haefaa
   2. Badbaran, Anita
   3. Bock, O
   4. Fehse, Boris
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Kröger, Nicolaus

   2010 - Forschungsinformationssystem des UKE
4. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

   1. Bacher, Ulrike
   2. Badbaran, Anita
   3. Fehse, Boris
   4. Zabelina, Tatjana
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
5. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
6. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

   1. Bacher, Ulrike
   2. Asenova, Svetlana
   3. Badbaran, Anita
   4. Zander, Axel R.
   5. Alchalby, Haefaa
   6. Fehse, Boris
   7. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
7. Syngenic graft-versus-chronic-myeloid-leukemia-effect?

   1. Ocheni, Sunday
   2. Schafhausen, Philippe
   3. Bacher, Ulrike
   4. Fehse, Boris
   5. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
8. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
9. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

   1. Bacher, Ulrike
   2. Zander, Axel R.
   3. Haferlach, T
   4. Schnittger, S
   5. Fehse, Boris
   6. Kröger, Nicolaus

   2008 - Forschungsinformationssystem des UKE
10. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

    1. Ayuketang Ayuk, Francis
    2. Diyachenko, Galina
    3. Zabelina, Tatjana
    4. Wolschke, Christine
    5. Fehse, Boris
    6. Bacher, Ulrike
    7. Erttmann, Rudolf

    2008 - Forschungsinformationssystem des UKE
11. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.

    1. Lioznov, Michael
    2. Badbaran, A
    3. Fehse, Boris
    4. Bacher, Ulrike
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2008 - Forschungsinformationssystem des UKE
12. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.

    1. Ayuketang Ayuk, Francis
    2. Diyachenko, Galina
    3. Zabelina, Tatjana
    4. Panse, Jens
    5. Wolschke, Christine
    6. Eiermann, Thomas
    7. Binder, Thomas

    2008 - Forschungsinformationssystem des UKE